Treatment of Chronic Tonsillitis in β-Hemolytic Streptococci Infection (Group A, C, or G) — McIsaac Score ≥ 3, Age 15 and Older

This protocol addresses patients aged 15 and older presenting with chronic tonsillitis in the setting of a highly suspected or confirmed β-hemolytic streptococcal infection (group A, C, or G), a McIsaac score of at least 3, and no penicillin allergy or incompatibility.

Clinical Scenario

Highly suspected or confirmed β-hemolytic streptococci infection (group A, C, or G)
McIsaac score of at least 3
Age 15 years and older
No penicillin allergy or incompatibility

Treatment Approach (Partial)

The structured regimen for this scenario centres on Penicillin V taken orally. The complete dosing, frequency, and duration are specified in the full protocol.

Treatment Goal

With adequate therapy, most patients — especially adolescents and adults — are free of symptoms within 48 hours.

Instant Access to Structured Evidence-Based Regimens

References

Antibiotic therapy is indicated only in case of a highly suspected or proven b-hemolytic streptococci infection (of group A, C, or G).

For patients with sore throat in times and regions without epidemic occurrence of b-hemolytic streptococcal infection, a low regional incidence of streptococcal sequelae and a McIsaac-Score of at least 3, oral medication is recommended as follows — Age 15 years and older:

Penicillin V (3 × 0.8–1.0 Mio IU/day for 7 days)

With adequate therapy, most of the patients, especially adolescents and adults, are free of symptoms within 48 h.

DOI: 10.1007/s00405-015-3872-6

View source ↗